Felipe Duran - 31 Mar 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Financial Officer
Signature: /s/ Felipe Duran
Issuer symbol: IBIO
Transactions as of: 31 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Apr 2023, 16:02:04 UTC
Previous filing: 14 Feb 2023
Next filing: 24 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBIO	Common Stock	Award	$0	+37,500	+1758%	$0.000000	39,633	31 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 37,500 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 37,500 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 37,500 RSUs vest pro rata quarterly over 12 months beginning April 1, 2023.

Content

Consists of 37,500 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 37,500 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 37,500 RSUs vest pro rata quarterly over 12 months beginning April 1, 2023.